Cargando…

Case Report: Successful Avatrombopag Treatment for Two Cases of Anti-PD-1 Antibody-Induced Acquired Amegakaryocytic Thrombocytopenia

Background: Anti-PD-1/PD-L1 immunotherapy has achieved impressive responses in multiple types of malignancies in recent years. However, immune-related adverse events (irAEs) occur and limit their continuous clinical use. Among these irAEs, acquired amegakaryocytic thrombocytopenia (AAT) is rare but...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tu, Xiaofang, Xue, Ali, Wu, Suye, Jin, Mengmeng, Zhao, Pu, Zhang, Hao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8830913/ https://www.ncbi.nlm.nih.gov/pubmed/35153753 http://dx.doi.org/10.3389/fphar.2021.795884

Ejemplares similares

Mononeuritis multiplex in acquired amegakaryocytic thrombocytopenia
por: Khan, Firosh, et al.
Publicado: (2015)

Acquired amegakaryocytic thrombocytopenia after durvalumab administration
por: Suyama, Takahiro, et al.
Publicado: (2021)

Acquired Amegakaryocytic Thrombocytopenia Progressing to Aplastic Anaemia
por: Hussain, Syed Ather, et al.
Publicado: (2022)

“Almost Bleeding to Death”: The Conundrum of Acquired Amegakaryocytic Thrombocytopenia
por: Brown, Gabrielle Elena, et al.
Publicado: (2014)

Acquired Amegakaryocytic Thrombocytopenia Associated With Autoimmune Hemolytic Anemia
por: Ikeda, Naoto, et al.
Publicado: (2022)

The name counts: the case of 'congenital amegakaryocytic thrombocytopenia'
por: Balduini, Carlo L.
Publicado: (2022)

Acquired Amegakaryocytic Thrombocytopenia and Pure Red Cell Aplasia in Thymoma
por: Dahal, Sumit, et al.
Publicado: (2018)

Acquired Amegakaryocytic Thrombocytopenia in Adult-onset Still's Disease: Successful Combination Therapy with Tocilizumab and Cyclosporine
por: Ichikawa, Takanori, et al.
Publicado: (2019)

Avatrombopag: A Review in Thrombocytopenia
por: Markham, Anthony
Publicado: (2021)

Marked rebound thrombocytosis in response to glucocorticoids in a patient with acquired amegakaryocytic thrombocytopenia
por: Nishino, Shogo, et al.
Publicado: (2018)

Avatrombopag for the treatment of thrombocytopenia induced by chemotherapy in patients with solid tumors: A multicenter, open-label, single-arm trial
por: Cui, Yayun, et al.
Publicado: (2022)

Efficacy and Safety of Avatrombopag in Patients With Thrombocytopenia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Li, Chunlu, et al.
Publicado: (2019)

Correction to: Avatrombopag: A Review in Thrombocytopenia
por: Markham, Anthony
Publicado: (2021)

Avatrombopag for the treatment of immune thrombocytopenia and thrombocytopenia of chronic liver disease
por: Cheloff, Abraham Z, et al.
Publicado: (2019)

Anti-CD20 Antibody is Effective in the Patient with Refractory Amegakaryocytic Thrombocytopenia, 25 Months Follow up
por: Mirzania, Mehrzad, et al.
Publicado: (2014)

Congenital Amegakaryocytic Thrombocytopenia: A Brief Review of the Literature
por: Al-Qahtani, Fatma S.
Publicado: (2010)

Thrombopoietin mutation in congenital amegakaryocytic thrombocytopenia treatable with romiplostim
por: Pecci, Alessandro, et al.
Publicado: (2017)

Radiation‑induced pure red cell aplasia combined with acquired amegakaryocytic thrombocytopenia in a thymoma after rapid response to radiotherapy: A case report and literature review
por: Xue, Yinyin, et al.
Publicado: (2023)

Clinical efficacy of avatrombopag and recombinant human thrombopoietin in the treatment of chronic liver disease-associated severe thrombocytopenia: A real-world study
por: Wang, Yong-Shuai, et al.
Publicado: (2022)

Myelodysplastic Syndrome Presenting as Amegakaryocytic Thrombocytopenia in a Collodion Baby
por: Al Pakra, Mohammed, et al.
Publicado: (2015)

Invasive Thymoma with Pure Red Cell Aplasia and Amegakaryocytic Thrombocytopenia
por: Onuki, Takuya, et al.
Publicado: (2016)

Thrombotic Complications in Immune Thrombocytopenia Patients Treated with Avatrombopag
por: Abdelsamia, Mahmoud, et al.
Publicado: (2023)

Acquired amegakaryocytic thrombocytopenia previously diagnosed as idiopathic thrombocytopenic purpura in a patient with hepatitis C virus infection
por: Ichimata, Shojiro, et al.
Publicado: (2017)

Danazol: An Effective Option in Acquired Amegakaryocytic Thrombocytopaenic Purpura
por: Mulroy, E., et al.
Publicado: (2015)

Pure red cell aplasia and amegakaryocytic thrombocytopenia in thymoma: The uncharted territory
por: Dragani, Matteo, et al.
Publicado: (2020)

Avatrombopag for the treatment of thrombocytopenia post hematopoietic stem-cell transplantation
por: Zhou, Meng, et al.
Publicado: (2022)

Mecom mutation related to radioulnar synostosis with amegakaryocytic thrombocytopenia reduces HSPCs in mice
por: Nagai, Koki, et al.
Publicado: (2023)

Cost- Effectiveness of Avatrombopag for the Treatment of Thrombocytopenia in Patients with Chronic Liver Disease
por: Mladsi, Deirdre, et al.
Publicado: (2020)

PB2637: OUR EXPERIENCE WITH AVATROMBOPAG TREATMENT IN PATIENTS WITH IMMUNE THROMBOCYTOPENIA
por: Cervinek, Libor
Publicado: (2023)

PB2623: AVATROMBOPAG FOR THE TREATMENT OF CHILDREN WITH PERSISTENT AND CHRONIC IMMUNE THROMBOCYTOPENIA
por: An, Qi, et al.
Publicado: (2023)

Haploidentical Hematopoietic Stem Cell Transplantation in a 3-Year-Old Girl with Congenital Amegakaryocytic Thrombocytopenia: A Case Report
por: Wang, Sisi, et al.
Publicado: (2022)

PB2066: SYSTEMIC LUPUS ERYTHEMATOSUS-INDUCED AMEGAKARYOCYTIC THROMBOCYTOPENIA AND SUBSEQUENT APLASTIC ANEMIA
por: Seong, Gyuhee, et al.
Publicado: (2023)

PB1946: ACQUIRED AMEGAKARYOCYTIC THROMBOCYTOPENA (AAMT), A SINGLE CENTER EXPERIENCE
por: Mohamed, S., et al.
Publicado: (2022)

Durability of platelet response after switching to avatrombopag from eltrombopag or romiplostim in immune thrombocytopenia
por: Al-Samkari, Hanny, et al.
Publicado: (2023)

Avatrombopag treatment response in patients with immune thrombocytopenia: the REAL-AVA 1.0 study
por: Oladapo, Abiola, et al.
Publicado: (2023)

Effectiveness and Safety of Avatrombopag in Liver Cancer Patients with Severe Thrombocytopenia: Real-World Data and Challenges
por: Huang, Ao, et al.
Publicado: (2022)

Real-world use of avatrombopag in patients with chronic liver disease and thrombocytopenia undergoing a procedure
por: Satapathy, Sanjaya K., et al.
Publicado: (2023)

Avatrombopag for adult chronic primary immune thrombocytopenia: a randomized phase 3 trial in China
por: Mei, Heng, et al.
Publicado: (2023)

Massive hemoperitoneum from hemorrhagic corpus luteum in a patient with acquired amegakaryocytic thrombocytopenic purpura
por: Obi, Esther Ifeoma, et al.
Publicado: (2020)

Current Advance in Thrombopoietin Receptor Agonists in the Management of Thrombocytopenia Associated With Chronic Liver Disease: Focus on Avatrombopag
por: Abdela, Jemal
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_popfiilqjs2ua5qd90e7v3j25m